Medtide Inc (3880)

Currency in HKD
28.54
+0.64(+2.29%)
Closed·
3880 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.3428.90
52 wk Range
26.7641.72
Key Statistics
Bid/Ask
28.54 / 28.54
Prev. Close
27.9
Open
28.68
Day's Range
28.34-28.9
52 wk Range
26.76-41.72
Volume
100.6K
Average Volume (3m)
151.41K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3880 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
39.46
Upside
+38.28%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Medtide Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Medtide Inc Company Profile

Medtide Inc., a contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services. It offers peptide new chemical entity discovery synthesis, peptide chemistry, manufacturing, and control development and commercial manufacturing services. The company focuses on developing oral and/or injectable glucagon, such as peptide-1 (GLP-1) molecule products. Its research and development technology platform include OmniPeptSynth, PeptiConjuX, PeptiNuclide LinkTech, GreenSynth Innovations, and Impurity Screening. It serves customers in China, the United States, Japan, Europe, South Korea, and Australia. The company was formerly known as Taide Pharmaceutical (Zhejiang) Co., Ltd and changed its name to Medtide Inc. in February 2023. Medtide Inc. was incorporated in 2020 and is headquartered in Hangzhou, China.

Compare 3880 to Peers and Sector

Metrics to compare
3880
Peers
Sector
Relationship
P/E Ratio
32.7x31.6x−0.6x
PEG Ratio
0.430.310.00
Price/Book
2.5x2.9x2.6x
Price / LTM Sales
7.3x6.1x3.4x
Upside (Analyst Target)
38.3%2.9%41.1%
Fair Value Upside
Unlock17.7%5.3%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 39.46
(+38.28% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Hold39.00+36.65%38.00MaintainDec 22, 2025

Earnings

Latest Release
Sep 25, 2025
EPS / Forecast
0.82 / --
Revenue / Forecast
253.77M / --
EPS Revisions
Last 90 days

3880 Income Statement

FAQ

What Is the Medtide (3880) Stock Price Today?

The Medtide stock price today is 28.54

What Stock Exchange Does Medtide Trade On?

Medtide is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Medtide?

The stock symbol for Medtide is "3880."

What Is the Medtide Market Cap?

As of today, Medtide market cap is 4.05B.

What Is Medtide's Earnings Per Share (TTM)?

The Medtide EPS (TTM) is 0.88.

From a Technical Analysis Perspective, Is 3880 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Medtide Stock Split?

Medtide has split 0 times.

How Many Employees Does Medtide Have?

Medtide has 520 employees.

What is the current trading status of Medtide (3880)?

As of Jan 18, 2026, Medtide (3880) is trading at a price of 28.54, with a previous close of 27.90. The stock has fluctuated within a day range of 28.34 to 28.90, while its 52-week range spans from 26.76 to 41.72.

What Is Medtide (3880) Price Target According to Analysts?

The average 12-month price target for Medtide is HKD39.46414588, with a high estimate of HKD39.46414588 and a low estimate of HKD39.46414588. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +38.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.